EconPapers    
Economics at your fingertips  
 

Nanotechnology Enters the Renal Cancer Drug Delivery Arena: A Review

Madhuri Sharon and Chetna Sharon
Additional contact information
Madhuri Sharon: Walchand Center for Research in Nanotechnology &Bio nanotechnology, India.
Chetna Sharon: Department of Internal Medicine, Hunter-Holmes McGuire, USA.

Novel Approaches in Drug Designing & Development, 2018, vol. 4, issue 2, 20-32

Abstract: Unique pharmacokinetics, minimal renal filtration, controllable size and shape, high surface-to-volume ratios, easy functionalization to attach ligands, therapeutic agents and navigating molecules so that they can be internalizedare the properties of nanoparticles that have been used to deliver drugs to various cancer cells. Entry of nanotechnology for targeted drug delivery to renal cancer is in its infancy. This review apprehends the arsenal of different types of nanocarriers available that can be used for selective tumor targeting, and challenges in renal cancer treatment. Nanocarriers are much smaller than cancer cells therefore can be taken-up through leaky blood vessels and interact with targeted tumor-specific proteins both on the surface and inside cancer cells. Use of nanoparticles to thermally ablate kidney cancer is also touched upon. This review suggests that in future, owing to the efficacy of these novel agents, the therapy of renal cancer appears promising.

Keywords: juniper publishers; drug designing pdf; drug designing articles; drug designing abstract; drug designing journal; modern approaches in drug designing journal; drug designing & intellectual properties international journal; peer reviewed open access journals; high impact journals; juniper publishers review (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/napdd/pdf/NAPDD.MS.ID.555631.pdf (application/pdf)
https://juniperpublishers.com/napdd/NAPDD.MS.ID.555631.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jnapdd:v:4:y:2018:i:2:p:20-32

DOI: 10.19080/NAPDD.2018.04.555631

Access Statistics for this article

Novel Approaches in Drug Designing & Development is currently edited by Sophia Mathis

More articles in Novel Approaches in Drug Designing & Development from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().

 
Page updated 2025-03-19
Handle: RePEc:adp:jnapdd:v:4:y:2018:i:2:p:20-32